PharmaOnco™ MART-1-Specific T cells (CAT#: ITS-0423-LX13)

Creative Biolabs offers MART-1-Specific T cells for immunity reaserch.

MART-1-specific T cells are a type of immune cell that specifically targets cells expressing the MART-1 antigen. MART-1 is a protein that is commonly expressed on melanoma cells, making it a target for immunotherapy in melanoma treatment. These T cells are engineered or activated to recognize and attack cells displaying MART-1, helping to eliminate melanoma cells from the body.

MART-1-Specific T cells are a type of T cells that are engineered to specifically target and attack cells that express the melanoma antigen recognized by T cells 1 (MART-1). MART-1 is a protein that is commonly expressed on melanoma cells, making it a target for immune-based therapies for melanoma. By engineering T cells to recognize and target MART-1, researchers hope to improve the effectiveness of immunotherapy for melanoma treatment.

Human

T cell population

We recommend RPMI-1640 with 10% FBS media for our functional analysis, but that depends on the media used by customers for co-culturing experiments.

High quality;
High viability;
Widely applications.

With proper stimulation, they will survive for about 4-5 days.

MART-1